IBDEI1TQ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32137,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,32137,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,32137,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,32138,0)
 ;;=L26.^^182^1981^148
 ;;^UTILITY(U,$J,358.3,32138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32138,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,32138,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,32138,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,32139,0)
 ;;=L27.0^^182^1981^266
 ;;^UTILITY(U,$J,358.3,32139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32139,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,32139,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,32139,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,32140,0)
 ;;=L27.1^^182^1981^267
 ;;^UTILITY(U,$J,358.3,32140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32140,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,32140,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,32140,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,32141,0)
 ;;=L29.0^^182^1981^251
 ;;^UTILITY(U,$J,358.3,32141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32141,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,32141,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,32141,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,32142,0)
 ;;=L29.9^^182^1981^252
 ;;^UTILITY(U,$J,358.3,32142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32142,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,32142,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,32142,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,32143,0)
 ;;=L30.0^^182^1981^233
 ;;^UTILITY(U,$J,358.3,32143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32143,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,32143,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,32143,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,32144,0)
 ;;=L30.1^^182^1981^140
 ;;^UTILITY(U,$J,358.3,32144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32144,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,32144,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,32144,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,32145,0)
 ;;=L30.2^^182^1981^132
 ;;^UTILITY(U,$J,358.3,32145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32145,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,32145,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,32145,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,32146,0)
 ;;=L30.4^^182^1981^144
 ;;^UTILITY(U,$J,358.3,32146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32146,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,32146,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,32146,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,32147,0)
 ;;=L30.8^^182^1981^135
 ;;^UTILITY(U,$J,358.3,32147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32147,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,32147,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,32147,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,32148,0)
 ;;=L30.9^^182^1981^136
 ;;^UTILITY(U,$J,358.3,32148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32148,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,32148,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,32148,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,32149,0)
 ;;=L40.0^^182^1981^254
 ;;^UTILITY(U,$J,358.3,32149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32149,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,32149,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,32149,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,32150,0)
 ;;=L40.1^^182^1981^257
 ;;^UTILITY(U,$J,358.3,32150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32150,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,32150,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,32150,2)
 ;;=^5009161
 ;;
 ;;$END ROU IBDEI1TQ
